Akebia Therapeutics, Inc.
做多

$AKBA - Fib run is testing 0.236 run of 100% likely.

436
AKBA is a heavily shorted bio-technology company that recently won DOD funding for one of their phase three candidates. I think the bullish trend is just getting started and a real shove will add 100% or more to the price of the stock.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。